new
   Side Effects, Management and Storage Guidelines for Sacubitril/Valsartan Sodium Tablets (Entresto)
528
May 29, 2026

Sacubitril/valsartan sodium tablets are highly effective in treating heart failure and hypertension, but like all medications, they may also cause some side effects.

I. What are the common side effects?

1. Hypotension:

This is the most common side effect, presenting as dizziness, fatigue, especially when standing up or getting up.

2. Hyperkalemia:

Excessively high blood potassium can lead to muscle weakness, arrhythmias, and in severe cases, life-threatening conditions.

3. Renal impairment:

(1) Including renal dysfunction and renal failure.

(2) Regular monitoring of serum creatinine and blood urea nitrogen levels is required during medication.

4. Cough:

Some patients may experience a dry cough, but the incidence is lower than with traditional ACEI antihypertensive drugs.

5. Angioedema:

(1) Although rare, it is a serious side effect. It manifests as swelling of the lips, eyelids, tongue, or throat, which may affect breathing.

(2) Other reactions: including dizziness, headache, fatigue, nausea, anemia, rash, etc. Most symptoms are mild and tolerable.

II. Identifying serious side effects

1. Warning signs requiring immediate medical attention:

(1) If you experience facial or throat swelling, difficulty breathing, or hoarseness, it may be angioedema requiring emergency treatment.

(2) Additionally, severe dizziness with loss of consciousness, severe chest pain, significantly reduced urine output, convulsions, or altered consciousness should prompt immediate medical attention.

2. Routine monitoring indicators:

(1) During treatment, regular checks of blood pressure, serum potassium, renal function (eGFR), and liver function should be performed.

(2) Typically, retesting within 2-4 weeks after starting medication or dose adjustment, then every 3-6 months once stabilized.

III. Ways to manage side effects

1. Managing hypotension:

(1) Rise slowly when getting up, pausing for a moment at each step from lying to sitting to standing.

(2) Avoid prolonged standing, hot baths, or excessive sweating. If dizziness occurs frequently, inform your doctor to adjust the dose.

2. Managing hyperkalemia:

(1) Avoid high-potassium foods such as bananas, oranges, potatoes, spinach, soy products, and low-sodium salt (which often contains potassium chloride).

(2) Consult your doctor for a dietary plan suitable for you.

3. Managing renal function fluctuations:

Maintain adequate fluid intake and avoid dehydration. Avoid concomitant use of NSAIDs (e.g., ibuprofen, diclofenac), as they can worsen kidney burden.

4. Managing cough and fatigue:

(1) Mild dry cough usually lessens over time.

(2) Fatigue is more common early in treatment; ensure adequate rest and avoid driving or operating dangerous machinery until you have adapted.

5. Managing rash or itching:

Avoid scratching, use a mild moisturizer. If the rash spreads or is accompanied by fever, seek medical evaluation.

IV. Contraindications and absolute precautions

1. The following conditions prohibit the use of this drug:

(1) Allergy to any ingredient; currently taking or less than 36 hours after stopping ACEI drugs; history of angioedema; severe hepatic impairment; pregnant or potentially pregnant women.

(2) Diabetic patients should not use this drug in combination with aliskiren.

V. Proper storage conditions

1. Temperature requirements:

(1) Store at room temperature, i.e., 15-25°C or a normal environment of 1-30°C.

(2) Avoid storing in humid, hot places such as bathrooms or kitchens.

2. Protect from light and moisture:

(1) Keep in the original packaging to protect from direct sunlight.

(2) Close the bottle cap tightly immediately after use.

3. Expiration date:

(1) The shelf life of both tablets and pediatric granules is 3 years.

(2) Do not use expired medication.

4. Child safety:

(1) Store out of reach of children.

(2) The capsule container of pediatric granules is the outer packaging; the inner microparticle tablets should be taken after removal. Do not swallow the whole capsule.

5. Disposal:

Expired or unused medication should be disposed of through proper take-back programs. Do not flush down the toilet or discard in household trash.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
RELATED ARTICLES
Contraindications and Special Populations of Brensocatib Tablets

The prescribing information for Brixocatib tablets indicates that there are no absolute contraindications, but...

Friday, August 7th, 2026, 17:16
Dosage and Administration of Isatuximab Injection (Sarclisa)

Sarclisa must be administered under the supervision of a healthcare professional, and the administration site must...

Friday, August 7th, 2026, 14:56
Indications and Dosage of Tepotinib

Tepotinib is an oral MET tyrosine kinase inhibitor indicated for the treatment of non-small cell lung cancer...

Thursday, August 6th, 2026, 15:43
Dosage and Administration of Zidesamtinib

Before the first administration of Ziditnib, the following baseline assessments must be completed:...

Thursday, August 6th, 2026, 15:41
RELATED MEDICATIONS
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved